Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022
Adverum Biotechnologies Announces Publication of Preclinical Long-Term Expression and Efficacy Data in Molecular Therapy
Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema
Bold Reports Positive Results of Induced Polarization Survey at Joutel - Signs Investor Awareness Agreement
SAGA Metals Highlights Historic $70 Billion Clean Energy Investment and Strategic Infrastructure Commitments in Labrador
Prince Silver Builds Momentum Toward Maiden Mineral Resource Estimate After Completing More than 10,000 m of Drilling
